Mira Kyivska

Will Core Scientific stock break $15.31 resistance amid strong buyer support?

Will Core Scientific stock break $15.31 resistance amid strong buyer support?
Core Scientific gains 7.96% to $14.17 today

Core Scientific (CORZ) stock is trading at $14.17, having gained 7.96% today. The share price is currently positioned above its key short- and medium-term moving averages, suggesting strong momentum on the session.

CORZ price prediction
24H 1.24%
$14.7
48H 2.62%
$14.9
7D 3.79%
$15.07
1M -20.04%
$11.61
3M -44.08%
$8.12
6M -46.49%
$7.77
12M -42.77%
$8.31
Current price: $14.52 0.1400 0.97%
Closed 11/13
Daily range 13.49 Arrow from to Icon 14.62
Weekly range 11.62 Arrow from to Icon 14.81
Loading...

Highlights

  • Core Scientific posted third quarter colocation revenue of $215 million, up nearly 60% sequentially amid strong services demand.
  • Adjusted EBITDA rose to $134 million from $41 million, indicating major profitability gains in the recent period.
  • Shares of Core Scientific advanced 7.96% to $14.17, with technicals indicating bullish momentum but localized overbought conditions and expected range of $12.79 to $15.31.

Profitability surge and revenue gains drive investor demand

Core Scientific reported a strong third quarter of 2026, with colocation revenue climbing nearly 60% sequentially to $215 million and adjusted EBITDA increasing to $134 million from $41 million, according to Scanx. These results highlight both strong demand for Core Scientific's services and a sharp improvement in profitability for the period. The operational gains and revenue momentum are supporting increased investor interest and contributing to the current upward movement.

Core Scientific asset chart
Core Scientific price dynamics. Source: TradingView.

Uptrend capped by long-term resistance as momentum indicators diverge

The price has crossed above both the MA-20 and MA-50 but remains under the MA-200, reflecting short- and medium-term positive momentum while encountering resistance from the longer-term trend ceiling. Immediate support is provided by the Ichimoku Kijun at $12.1, while the nearest resistance sits at $15.31. Momentum signals are constructive: MACD and ADX indicate a buy bias, supported by the Awesome Oscillator. However, RSI remains neutral, and both Stoch RSI and CCI are in overbought territory, pointing to short-term overheating. Bull/Bear Power is positive at 0.48, confirming persistent buyer strength despite cautionary signs from the oscillators.

Upside bias prevails as price nears breakout threshold

Looking ahead, typical volatility may keep CORZ within a $12.79 to $15.31 band over the next several sessions. The bullish scenario would be triggered by a decisive break above $15.31 resistance, unlocking further upside. Conversely, if the price drops below immediate support at $12.1, a corrective pullback could develop. The base case involves consolidation between these bounds, with a 79% probability favoring further upside continuation versus a 21% likelihood of a short-term reversal.

Viktoras Karapetjanc, expert at Traders Union, sees Core Scientific’s strong Q3 2026 results as a clear signal of rising institutional and client demand. He notes that this surge in operational profitability has meaningfully boosted sentiment, with momentum and technicals now favoring upside. The analyst points out that fundamentals are aligning with the market’s bullish tone, increasing the likelihood of a sustained breakout. "With revenue and EBITDA expanding at this pace, I believe CORZ remains well positioned for further gains as long as $12.1 support holds and bullish momentum persists."

Earlier, analysts noted that Core Scientific was in a strategic transition away from Bitcoin mining, with mixed short- and long-term momentum indicators suggesting cautious optimism for future performance. The current breakout above key moving averages, supported by robust operational gains, positions $15.31 as the crucial resistance level to monitor for a potential upside extension in the coming sessions.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.